(GINA) 2006 - Global Initiative for Asthma

More documents

Recommendations

Info

Progetto LIBRA, www.progettolibra.it Traduzione a cura di Antonella Di Franco e Pierluigi Paggiaro Dipartimento Cardio-Toracico e Vascolare dell'Università di Pisa
GINA EXECUTIVE COMMITTEE* Paul O'Byrne, MD, Chair McMaster University Hamilton, Ontario, Canada Eric D. Bateman, MD University of Cape Town Cape Town, South Africa Jean Bousquet, MD, PhD Montpellier University and INSERM Montpellier, France Tim Clark, MD National Heart and Lung Institute London, United Kingdom Ken Ohta. MD, PhD Teikyo University School of Medicine Tokyo, Japan Pierluigi Paggiaro, MD University of Pisa Pisa, Italy Soren Erik Pedersen, MD Kolding Hospital Kolding, Denmark Manuel Soto-Quiroz, MD Hospital Nacional de Niños San José, Costa Rica Raj B Singh MD Apollo Hospital Chennai, India Wan-Cheng Tan, MD St Paul's Hospital, Vancouver, BC, Canada GINA SCIENCE COMMITTEE* Eric D. Bateman, MD, Chair University of Cape Town Cape Town, South Africa Peter J. Barnes, MD National Heart and Lung Institute London, UK Jean Bousquet, MD, PhD Montpellier University and INSERM Montpellier, France Jeffrey M. Drazen, MD Harvard Medical School Boston, Massachusetts, USA Mark FitzGerald, MD University of British Columbia Vancouver, BC, Canada Peter Gibson, MD John Hunter Hospital NSW, New Castle, Australia Paul O'Byrne, MD McMaster University Hamilton, Ontario, Canada Ken Ohta. MD, PhD Teikyo University School of Medicine Tokyo, Japan Soren Erik Pedersen, MD Kolding Hospital Kolding, Denmark Strategia Globale per la Gestione e Prevenzione dell’Asma - Aggiornamento 2006 Emilio Pizzichini. MD Universidade Federal de Santa Catarina Florianópolis, SC, Brazil Sean D. Sullivan, PhD University of Washington Seattle, Washington, USA Sally E. Wenzel, MD National Jewish Medical/Research Center Denver, Colorado, USA Heather J. Zar, MD University of Cape Town Cape Town, South Africa REVIEWERS Louis P. Boulet, MD Hopital Laval Quebec, QC, Canada William W. Busse, MD University of Wisconsin Madison, Wisconsin USA Neil Barnes, MD The London Chest Hospital, Barts and the London NHS Trust London, United Kingdom Yoshinosuke Fukuchi, MD, PhD President, Asian Pacific Society of Respirology Tokyo, Japan John E. Heffner, MD President, American Thoracic Society Providence Portland Medical Center Portland, Oregon USA Dr. Mark Levy Kenton Bridge Medical Centre Kenton, United Kingdom Carlos M. Luna, MD President, ALAT University of Buenos Aires Buenos Aires, Argentina Dr. Helen K. Reddel Woolcock Institute of Medical Research Camperdown, New South Wales, Australia Stanley Szefler, MD National Jewish Medical & Research Center Denver, Colorado USA GINA Assembly Members Who Submitted Comments Professor Nguygen Nang An Bachmai University Hospital Hanoi, Vietnam Professor Richard Beasley Medical Research Institute New Zealand Wellington, New Zealand Yu-Zi Chen, MD Children's Hospital of The Capital Institute of Pediatrics Beijing, China Ladislav Chovan, MD, PhD President, Slovak Pneumological and Phthisiological Society Bratislava, Slovak Republic Motohiro Ebisawa, MD, PhD National Sagamihara Hospital/Clinical Research Center for Allergology Kanagawa, Japan Professor Amiran Gamkrelidze Tbilisi, Georgia Dr. Michiko Haida Hanzomon Hospital, Chiyoda-ku, Tokyo, Japan Dr. Carlos Adrian Jiménez San Luis Potosí, México Sow-Hsong Kuo, MD National Taiwan University Hospital Taipei, Taiwan Eva Mantzouranis, MD University Hospital Heraklion, Crete, Greece Dr. Yousser Mohammad Tishreen University School of Medicine Lattakia, Syria Hugo E. Neffen, MD Children Hospital Santa Fe, Argentina Ewa Nizankowska-Mogilnicka, MD University School of Medicine Krakow, Poland Afshin Parsikia, MD, MPH Asthma and Allergy Program Iran Jose Eduardo Rosado Pinto, MDHospital Dona Estefania Lisboa, Portugal Joaquín Sastre, MD Universidad Autonoma de Madrid Madrid, Spain Dr. Jeana Rodica Radu N. Malaxa Hospital Bucharest, Romania Mostafizur Rahman, MD Director and Head, NIDCH Dhaka, Bangladesh Vaclav Spicak, MD Czech Initiative for Asthma Prague, Czech Republic G.W. Wong, MD Chinese University of Hong Kong Hong Kong, China GINA Program Suzanne S. Hurd, PhD Scientific Director Sarah DeWeerdt Medical Editor *(*Disclosures for members of GINA Executive and Science Committees can be found at:http://www.ginasthma.com/Committees.asp?l1=7&l2=2 ). i
Page 4 and 5: L’asma rappresenta un grave probl
Page 6 and 7: β 2 -agonisti inalatori a lunga du
Page 8 and 9: L‘asma rappresenta un grave probl
Page 10 and 11: Alcuni dei più importanti cambiame
Page 12 and 13: INTRODUZIONE Le prime Linee Guida d
Page 14 and 15: Controllato e Non Controllato. Il c
Page 16 and 17: Una dose di glucocorticosteroidi or
Page 18 and 19: MESSAGGI PRINCIPALI • L’asma è
Page 20 and 21: FATTORI CHE INFLUENZANO IL RISCHIO
Page 22 and 23: asma può dipendere da altre caratt
Page 24 and 25: Figura 1-4: Cellule infiammatorie d
Page 26 and 27: BIBLIOGRAFIA 1. Vincent SD, Toelle
Page 28 and 29: 66. Bernstein IL, Chan-Yeung M, Mal
Page 30 and 31: 14 DEFINIZIONE ED INQUADRAMENTO GEN
Page 32 and 33: MESSAGGI PRINCIPALI • La diagnosi
Page 34 and 35: sesso e altezza sono stati ottenuti
Page 36 and 37: considerevole perizia e, se non eff
Page 38 and 39: specializzati per eseguire tali acc
Page 40 and 41: BIBLIOGRAFIA 1. Levy ML, Fletcher M
Page 42 and 43: 26 DIAGNOSI E CLASSIFICAZIONE
Page 44 and 45: MESSAGGI PRINCIPALI • I farmaci p
Page 46 and 47: la frequenza e la gravità delle ri
Page 48 and 49: formulazione a lento rilascio che l
Page 50 and 51: sistemici in pazienti asmatici mala
Page 52 and 53:
evitati con un adeguato dosaggio e
Page 54 and 55:
Bambini di età superiore ai 5 anni
Page 56 and 57:
Bambini più grandi di 5 anni. I br
Page 58 and 59:
9. Juniper EF, Kline PA, Vanzielegh
Page 60 and 61:
72. Palmqvist M, Persson G, Lazer L
Page 62 and 63:
140. Pedersen S. Do inhaled cortico
Page 64 and 65:
48 TRATTAMENTO DELL’ASMA
Page 66 and 67:
INTRODUZIONE L’asma è una malatt
Page 68 and 69:
Comunicazioni chiare tra operatori
Page 70 and 71:
Autogestione nei bambini I bambini
Page 72 and 73:
definiti sulle strategie combinate
Page 74 and 75:
Vaccinazione antinfluenzale I pazie
Page 76 and 77:
sebbene non abbiano una identica ef
Page 78 and 79:
da bombolette pressurizzate (MDI),
Page 80 and 81:
corso di glucocorticosteroidi orali
Page 82 and 83:
con le prove di funzionalità respi
Page 84 and 85:
c’è una mancata risposta o ci so
Page 86 and 87:
Trattamento In genere è richiesto
Page 88 and 89:
assicurandosi che siano possibili c
Page 90 and 91:
l’ostruzione nasale è causata da
Page 92 and 93:
eseguite in centri specializzati 33
Page 94 and 95:
49. Kulig M, Luck W, Lau S, Niggema
Page 96 and 97:
119. Ram FS, Robinson SM, Black PN.
Page 98 and 99:
182. Busse W, Corren J, Lanier BQ,
Page 100 and 101:
249. Lee-Wong M, Dayrit FM, Kohli A
Page 102 and 103:
321. Barish CF, Wu WC, Castell DO.
Page 104 and 105:
MESSAGGI PRINCIPALI • Linee Guida
Page 106 and 107:
sanità pubblica competente ed ai b
Page 108 and 109:
2. Higgins BG, Britton JR, Chinn S,
Page 110:
Adattamento Italiano delle Linee Gu
show all

(GINA) 2006 - Global Initiative for Asthma

Create successful ePaper yourself

Delete template?

Save as template?